Related Experiment Video
Updated: Jun 13, 2026
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
Rapid detection of epidermal growth factor receptor mutations with multiplex PCR and primer extension in lung cancer
Ching-Hsiung Lin1, Kun-Tu Yeh, Ya-Sian Chang
1Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Abstract:
Epidermal growth factor receptor (EGFR) kinase domain mutations hyperactivate the kinase and confer kinase addiction of the non-small-cell lung cancer (NSCLC) tumor cells. Almost all of these mutations are located within exons 18-21. The -216 single nucleotide polymorphism in the promoter region is associated with increased EGFR production. We present a method for detecting these common mutations in 81 cases of NSCLC. The protocol is based on the multiplex amplification of promoter region and exons 18-21 of the EGFR genes in a single tube, followed by primer extension of the PCR products using various sizes of primers to detect base changes at -216 promoter region and codons 719, 746-750, 790, 858 of the EGFR gene. We compared the results with that from direct sequencing for detecting EGFR mutations in 81 cases of NSCLC. The two methods identified the same 26 mutations, but our method is superior to direct sequencing in terms of the amount of work and time required. We presented a simple and fast method to detect mutations of EGFR genes in NSCLC.
Insights
A new method efficiently detects epidermal growth factor receptor (EGFR) mutations in non-small-cell lung cancer (NSCLC). This faster, simpler approach aids in identifying key genetic alterations for targeted therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Epidermal growth factor receptor (EGFR) kinase domain mutations drive non-small-cell lung cancer (NSCLC) progression.
- These mutations, primarily in exons 18-21, lead to kinase addiction in cancer cells.
- A promoter polymorphism (-216) is linked to increased EGFR expression.
Purpose of the Study:
- To develop and validate a rapid, multiplex method for detecting common EGFR mutations in NSCLC.
- To assess the efficiency of this new method compared to direct sequencing.
Main Methods:
- Multiplex amplification of EGFR promoter and exons 18-21 in a single tube.
- Primer extension PCR to detect specific mutations at the promoter region and key codons.
- Validation against direct sequencing in 81 NSCLC cases.
Main Results:
- The novel method successfully identified 26 EGFR mutations in the NSCLC cohort.
- The developed assay demonstrated comparable accuracy to direct sequencing.
- This multiplex approach significantly reduces the time and labor required for mutation detection.
Conclusions:
- A simple, fast, and efficient multiplex method for detecting EGFR mutations in NSCLC has been established.
- This assay offers a superior alternative to direct sequencing for clinical application.
- The method facilitates timely identification of actionable EGFR mutations in NSCLC patients.
